Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vitamin K Antagonist”

132 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 132 results

Not applicableLooking for participantsNCT02219984
What this trial is testing

START-Register: Survey on Anticoagulated Patients Register

Who this might be right for
Atrial FibrillationVenous ThromboembolismHeart Valve Diseases or Prosthesis
GUALTIERO PALARETI 15,410
Not applicableStudy completedNCT04195113
What this trial is testing

Perioperative Anticoagulant Use for Surgery Evaluation Emergency Registry

Who this might be right for
Atrial FibrillationVenous ThromboembolismArterial Vascular Disease
McMaster University 242
Not applicableStudy completedNCT01349530
What this trial is testing

Evaluating of CREATIF an Anti-coagulation Clinic

Who this might be right for
Vitamin K Antagonist
Assistance Publique - Hôpitaux de Paris 110
Not applicableStudy completedNCT05195372
What this trial is testing

Effectivity and Safety of Different Anticoagulants in Patients With Thromboembolic Antiphospholipid Syndrome

Who this might be right for
Antiphospholipid SyndromeVenous ThromboembolismArterial Thromboembolism+1 more
Cardioangiologisches Centrum Bethanien 80
Large-scale testing (Phase 3)Active Not RecruitingNCT05825573
What this trial is testing

Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus

Who this might be right for
Intracardiac ThrombusSTEMIHeart Failure
Centre Hospitalier Universitaire de Nīmes 340
Large-scale testing (Phase 3)Study completedNCT02866175
What this trial is testing

Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 1,506
Not applicableStudy completedNCT02596230
What this trial is testing

RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim 7,797
Not applicableStudy completedNCT04505475
What this trial is testing

Oral Surgery in Patients Taking Direct Oral Anticoagulants

Who this might be right for
Anticoagulants and Bleeding DisordersSurgeryPostoperative Hemorrhage+1 more
University of Novi Sad 82
Not applicableUnknownNCT02906527
What this trial is testing

Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 75 Years and Over Suffering From Non Valvular Atrial Fibrillation (nv AF)

Who this might be right for
Non Valvular Atrial Fibrillation (nv AF)
Assistance Publique - Hôpitaux de Paris 150,000
Not applicableStudy completedNCT03826927
What this trial is testing

New Oral Anticoagulants (NOAC) in Stroke Patients

Who this might be right for
StrokeAtrial Fibrillation
University Hospital, Basel, Switzerland 1,023
Large-scale testing (Phase 3)Looking for participantsNCT04066764
What this trial is testing

Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters

Who this might be right for
Venous Thromboembolism
Second Affiliated Hospital, School of Medicine, Zhejiang University 200
Not applicableStudy completedNCT04062097
What this trial is testing

Registration of Idarucizumab for Patients with IntraCranial Hemorrhage

Who this might be right for
Intracranial Hemorrhage
University Hospital, Essen 104
Large-scale testing (Phase 3)Looking for participantsNCT04284839
What this trial is testing

The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial

Who this might be right for
Bleeding Post Cardiac SurgeryIndication for Anticoagulation
Population Health Research Institute 3,500
Not applicableStudy completedNCT02687867
What this trial is testing

Real-world Comparative Effectiveness of Dabigatran Versus Vitamin K Antagonist

Who this might be right for
Atrial Fibrillation
Bayer 56,039
Not applicableStudy completedNCT02960880
What this trial is testing

Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Rivaroxaban vs. Vitamin k Antagonists

Who this might be right for
Atrial Fibrillation
Bayer 99,999
Not applicableStudy completedNCT01660061
What this trial is testing

Monitoring Anticoagulant Therapy in Antiphospholipid Syndrome

Who this might be right for
Antiphospholipid Syndrome
Johann Wolfgang Goethe University Hospital 150
Not applicableLooking for participantsNCT05646394
What this trial is testing

Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS

Who this might be right for
Antiphospholipid SyndromeArterial Thrombosis
McMaster University 150
Not applicableStudy completedNCT02597920
What this trial is testing

Patient Convenience Study

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 1,852
Not applicableStudy completedNCT02687854
What this trial is testing

Real-world Comparative Effectiveness of Apixaban Versus Vitamin K Antagonist

Who this might be right for
Atrial Fibrillation
Bayer 18,591
Not applicableStudy completedNCT03914053
What this trial is testing

Balancing of Patients Treated by Vitamin K Antagonists (VKAS) in General Medicine

Who this might be right for
Thromboembolism
University Hospital, Montpellier 3,387
Load More Results